滨州医学院学报2024,Vol.47Issue(2) :122-125.DOI:10.19739/j.cnki.issn1001-9510.2024.02.008

乙酰肝素酶、硫酸乙酰肝素和多配体蛋白聚糖-1在肺癌患者血清中的表达及诊断价值

Expression of heparinase,heparan sulfate and syndecan-1 in serum of lung cancer patients and diagnostic value

李涛 高萌 翟乃亮
滨州医学院学报2024,Vol.47Issue(2) :122-125.DOI:10.19739/j.cnki.issn1001-9510.2024.02.008

乙酰肝素酶、硫酸乙酰肝素和多配体蛋白聚糖-1在肺癌患者血清中的表达及诊断价值

Expression of heparinase,heparan sulfate and syndecan-1 in serum of lung cancer patients and diagnostic value

李涛 1高萌 2翟乃亮1
扫码查看

作者信息

  • 1. 滨州医学院附属医院呼吸与危重症医学科 山东 滨州 256603
  • 2. 烟台山医院呼吸与危重症医学科 山东 烟台 264000
  • 折叠

摘要

目的 探讨多配体蛋白聚糖-1(SDC-1)、硫酸乙酰肝素(HS)以及乙酰肝素酶(HPA)在非小细胞肺癌(NSCLC)及小细胞肺癌(SCLC)患者血清中的水平及其对诊断及预后的预测价值.方法 收集 10 例健康对照组及 76 例肺癌患者的血清标本,通过ELISA方法检测血清中HS、SDC-1、HPA表达水平.采用Mann-Whitney U检验进行组间比较.结果 肺癌患者血清HS、SDC-1 及HPA含量均高于健康对照组(P<0.05);HS、HPA单因素用于诊断肺癌时的AUC分别为0.819和0.930,HS、SDC-1、HPA三者联合诊断肺癌时AUC为 0.974.结论 HS、SDC-1、HPA三者联合检测对肺癌的诊断及预后具有较好的预测价值.

Abstract

Objective To investigate the serum levels of syndecan-1(SDC-1),heparan sulfate(HS)and heparanase(HPA)in patients with non-small cell lung cancer(NSCLC)and small cell lung cancer(SCLC),and diagnostic and predictive value.Methods We collected serum samples from 10 healthy volunteers and 76 lung cancer patients,and detected the expres-sion of HS,SDC-1 and HPA in serum by ELISA.Mann-Whitney Utest is used to compare with each group.Results The serum levels of HS,SDC-1 and HPA in lung cancer patients were higher than those in healthy volunteers.The AUC of HS and HPA in the diagnosis of lung cancer was 0.819 and 0.930 respectively.The AUC of HS,SDC-1 and HPA in the diagnosis of lung cancer was 0.974.Conclusion Co-detection of HS,HPA and SDC-1 could have important diagnostic and predictive value for lung canc-er.

关键词

多配体蛋白聚糖-1/硫酸乙酰肝素/乙酰肝素酶/肺癌

Key words

syndecan-1/heparan sulfate/heparinase/lung cancer

引用本文复制引用

基金项目

国家自然科学基金(82200082)

山东省医药卫生发展计划(2018WS546)

出版年

2024
滨州医学院学报
滨州医学院

滨州医学院学报

影响因子:0.548
ISSN:1001-9510
参考文献量15
段落导航相关论文